Virtus Biotech ETF
13 hedge funds and large institutions have $10.4M invested in Virtus Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
12% more capital invested
Capital invested by funds: $9.34M → $10.4M (+$1.09M)
8% more funds holding
Funds holding: 12 → 13 (+1)
1.55% less ownership
Funds ownership: 41.56% → 40.01% (-1.5%)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$98.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 3 |
Morgan Stanley
New York
|
+$804 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$680K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$568K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$76.1K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$3.98K |
| 5 |
LPL Financial
San Diego,
California
|
-$3.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5.49M | -$568K | -12,724 | -10% |
|
|
SMG
2
Smart Money Group
Eastland,
Texas
| $2.85M | -$3.48K | -78 | -0.1% |
|
|
FAIM
3
Financial Advocates Investment Management
Olympia,
Washington
| $552K | – | – | – |
|
|
4
LPL Financial
San Diego,
California
| $378K | -$3.62K | -81 | -1% |
|
|
5
Citadel Advisors
Miami,
Florida
| $367K | -$76.1K | -1,703 | -18% |
|
|
6
Stifel Financial
St. Louis,
Missouri
| $357K | -$3.98K | -89 | -1% |
|
|
PAG
7
Private Advisor Group
Morristown,
New Jersey
| $104K | +$98.3K | +2,200 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $101K | +$19.9K | +446 | +27% |
|
|
9
Morgan Stanley
New York
| $88K | +$804 | +18 | +1% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $76K | – | – | – |
|
|
RWB
11
RMR Wealth Builders
Montclair,
New Jersey
| $41K | +$38.9K | +871 | New |
|
|
FWM
12
Focused Wealth Management
Newburgh,
New York
| $33K | – | – | – |
|
|
CFB
13
Cullen/Frost Bankers
San Antonio,
Texas
| $3K | – | – | – |
|
|
14
Jane Street
New York
| – | -$680K | -18,165 | Closed |
|
BBP Hedge Fund Activity: Q2 2020 in Review
13 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2020, worth a combined $10.4M — up 12% from $9.34M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BBP positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $98.3K. The largest seller was Jane Street, exiting entirely with an estimated $680K sold.
- 13 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2020, up from 12 in Q1 2020.
- Funds reported $10.4M of Virtus Biotech ETF stock for Q2 2020, up 12% quarter-over-quarter.
- 2 funds opened new Virtus Biotech ETF positions in Q2 2020 and 1 closed out, a net change of +1 holder.
- The largest Virtus Biotech ETF buyer in Q2 2020 was Private Advisor Group, an estimated $98.3K added.
- The largest Virtus Biotech ETF seller in Q2 2020 was Jane Street, an estimated $680K sold.
Based on aggregated 13F filings for Q2 2020.